Vernal Biosciences

Vernal Biosciences

The mRNA Monthly—June 2025 Edition

June Monthly Newsletter

Advancements in Biopharma Spur Innovation Christian Cobaugh, chief scientific officer and founder of Vernal Biosciences, offered PharmaTech editor Susan Haigney comments about where he believes mRNA and LNP advancements fit into the biopharm innovation landscape. Source: Pharmaceutical Technology, June 2025,…

How mRNA Saved an Innovator’s Program

Well-Defined mRNA Platform Processes & Collaboration Advanced a Novel Gene Therapy in Jeopardy Learn how Vernal Bio changed the course of a stalled cancer gene therapy program, pairing proven mRNA platform methods with scientific flexibility and hands-on collaboration. Innovator’s Challenges…

The mRNA Monthly—May 2025 Edition

The mRNA Monthly May 2025 Edition

Awakening the Giant: The Next Frontier in mRNA Therapeutics We’ve seen what mRNA can do in vaccines—but that was only the beginning. In a new article published in American Pharmaceutical Review , Vernal’s CSO Christian Cobaugh, Ph.D., outlines how mRNA…

The mRNA Monthly—April 2025 Edition

The mRNA Monthly April 2025 Edition

The Evolving Needs of Therapeutic mRNA Developers Insights on the next wave of challenges mRNA innovators face as an increasing number of therapeutics move through the pipeline. Read Article Behind the Headlines Panel Discussion Christian Cobaugh, Ph.D., Vernal Biosciences founder…

Advancing mRNA Therapeutics

How Vernal Helped Akagera Boost Vaccine Efficacy, Cut Costs, and Speed Development Pioneering mRNA Therapies for Infectious Diseases in Cost-Sensitive Regions Founded in 2019, Akagera Medicines is advancing novel liposomal formulations of antibacterial drugs to enhance drug delivery and uptake…

Cas9 mRNA: Gene Editing Advantages

CRISPR/Cas9 RNA-DNA complex

CRISPR-Cas9 RNA-DNA complex. Structure of Cas9 endonuclease (yellow-orange) complexed with a guide RNA (blue), a target DNA (pink) and a non-target DNA (green).  The revolutionary CRISPR-Cas gene editing technology has unlocked unprecedented possibilities in genome engineering, gene therapy, and cell…